Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05569044 · ClinicalTrials.gov registry record · NA
Oral Rehydration Solutions in Healthy Adult Athletes
A NA study, sponsored by Abbott Nutrition.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT05569044: Clinical Trial NA study, sponsored by Abbott Nutrition.
NCT05569044 is a NA study that was terminated before completion, run by Abbott Nutrition. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05569044, a NA study, was terminated before completion, sponsored by Abbott Nutrition.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This is a prospective, randomized, controlled, crossover study to determine the benefits of adult athletes consuming an oral rehydration solution (ORS) with exercise.
Primary Outcome
Change in cycling power
Interventions
- OTHER Control Group
- OTHER Water
- OTHER Oral Rehydration Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-11-21 |
| Est. Completion | 2024-06-18 |
| Phase | NA |
Why NCT05569044 stopped before completion
NCT05569044 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Control Group is the first listed.
NCT05569044 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05569044 about?
NCT05569044 is a clinical study titled "Oral Rehydration Solutions in Healthy Adult Athletes". This is a prospective, randomized, controlled, crossover study to determine the benefits of adult athletes consuming an oral rehydration solution (ORS) with exercise.
What is the current status of trial NCT05569044?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2022-11-21. Estimated completion is 2024-06-18.
What interventions are being tested in trial NCT05569044?
The interventions under investigation include: Control Group (OTHER), Water (OTHER), Oral Rehydration Solution (OTHER).
Who is sponsoring clinical trial NCT05569044?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05569044's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI